From the ∗Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta

†Synergy America, Inc., Duluth

‡Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA

Acknowledgments: The authors thank Mariela Scarbrough and Juanita Onyekwuluje, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, for their exceptional work in the HPV laboratory.

Author contributions: R.M.L., J.W.G., and L.E.M. designed the study. T.D.Q. and E.R.U. were responsible for overseeing specimen testing and laboratory processes. R.M.L. performed data analysis and drafted the initial manuscript. All authors contributed to interpretation of the data, development of the final manuscript, and offered scientific expertise.

Source of Funding: Supported by Centers for Disease Control and Prevention.

Conflict of Interest: None declared.

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Correspondence: Rayleen M. Lewis, MPH, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS H24-5, Atlanta, GA 30329. E-mail: [email protected].

Received for publication November 19, 2020, and accepted April 16, 2021.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (http://www.stdjournal.com).